Smith & Nephew PLC (LSE:SN) — Market Cap & Net Worth

$119.65 Million USD · GBX983.39 Billion GBX · Rank #18443

Market Cap & Net Worth: Smith & Nephew PLC (SN)

Smith & Nephew PLC (LSE:SN) has a market capitalization of $119.65 Million (GBX983.39 Billion) as of August 2, 2026. Listed on the LSE stock exchange, this UK-based company holds position #18443 globally and #104 in its home market, demonstrating a 3.58% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Smith & Nephew PLC's stock price GBX1158.50 by its total outstanding shares 848850481 (848.85 Million). See capital reinvestment ratio of Smith & Nephew PLC to understand how much of operating cash flow is reinvested back into capital assets.

Smith & Nephew PLC Market Cap History: 2015 to 2026

Smith & Nephew PLC's market capitalization history from 2015 to 2026. Data shows growth from $97.40 Million to $119.65 Million (2.38% CAGR).

Index Memberships

Smith & Nephew PLC is a constituent of 6 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
FTSE All-Share FTAS	$72.38 Billion	0.17%	#59 of 573
FTSE 350 FTLC	$71.98 Billion	0.17%	#57 of 350
FTSE 100 Index (UK) FTSE	$56.28 Billion	0.21%	#49 of 100
STOXX Europe Large 200 EUR Price LCXP	$7.22 Trillion	0.00%	#148 of 182
STOXX Europe Large 200 Net Return LCXR	$7.22 Trillion	0.00%	#148 of 182
FTSE 350 Health Care Equipment & Services NMX4530	$184.16 Million	64.97%	#1 of 3

Weight: Smith & Nephew PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Smith & Nephew PLC Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Smith & Nephew PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.02x

Smith & Nephew PLC's market cap is 0.02 times its annual revenue

Industry average: 3.51x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.20x

Smith & Nephew PLC's market cap is 0.20 times its annual earnings

Industry average: 110.65x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$100.36 Million	$4.67 Billion	$784.00 Million	0.02x	0.13x
2017	$108.07 Million	$4.76 Billion	$767.00 Million	0.02x	0.14x
2018	$126.27 Million	$4.90 Billion	$663.00 Million	0.03x	0.19x
2019	$161.62 Million	$5.14 Billion	$600.00 Million	0.03x	0.27x
2020	$136.72 Million	$4.56 Billion	$448.00 Million	0.03x	0.31x
2021	$120.43 Million	$5.21 Billion	$524.00 Million	0.02x	0.23x
2022	$106.77 Million	$5.21 Billion	$223.00 Million	0.02x	0.48x
2023	$107.56 Million	$5.55 Billion	$263.00 Million	0.02x	0.41x
2024	$102.39 Million	$5.81 Billion	$412.00 Million	0.02x	0.25x
2025	$127.91 Million	$6.29 Billion	$638.11 Million	0.02x	0.20x

Competitor Companies of SN by Market Capitalization

Companies near Smith & Nephew PLC in the global market cap rankings as of August 2, 2026.

Key companies related to Smith & Nephew PLC by market ranking:

Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#114	Abbott Laboratories	NYSE:ABT	$183.80 Billion	$105.70
#189	Stryker Corporation	NYSE:SYK	$124.64 Billion	$325.70
#233	Medtronic plc	SA:MDTC34	$104.84 Billion	R$208.39
#238	Medtronic PLC	NYSE:MDT	$103.60 Billion	$85.39

Smith & Nephew PLC Historical Marketcap From 2015 to 2026

Between 2015 and today, Smith & Nephew PLC's market cap moved from $97.40 Million to $ 119.65 Million, with a yearly change of 2.38%.

Year	Market Cap	Change (%)
2026	GBX119.65 Million	-6.46%
2025	GBX127.91 Million	+24.92%
2024	GBX102.39 Million	-4.80%
2023	GBX107.56 Million	+0.74%
2022	GBX106.77 Million	-11.35%
2021	GBX120.43 Million	-11.91%
2020	GBX136.72 Million	-15.41%
2019	GBX161.62 Million	+28.00%
2018	GBX126.27 Million	+16.84%
2017	GBX108.07 Million	+7.69%
2016	GBX100.36 Million	+3.03%
2015	GBX97.40 Million	--

End of Day Market Cap According to Different Sources

On Aug 1st, 2026 the market cap of Smith & Nephew PLC was reported to be:

Source	Market Cap
Yahoo Finance	$119.65 Million USD
MoneyControl	$119.65 Million USD
MarketWatch	$119.65 Million USD
marketcap.company	$119.65 Million USD
Reuters	$119.65 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Smith & Nephew PLC

LSE:SN UK Medical Devices

Market Cap

$119.65 Million

GBX983.39 Billion GBX

Market Cap Rank

#18443 Global

#104 in UK

Share Price

GBX1158.50

Change (1 day)

-2.48%

52-Week Range

GBX1073.50 - GBX1435.00

All Time High

GBX1690.00